This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hawari, F. I Articles by Izzo, J. L Search for Related Content PubMed PubMed Citation Articles by Hawari, F. I Articles by Izzo, J. L, Jr Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Blood Thinners Hazardous Substances DB HEPARIN METHYLENE BLUE Social Bookmarking                         What's this?

Heparin attenuates norepinephrine-induced venoconstriction

Department of Medicine, State University of New York at Buffalo, Buffalo, NY, USA

Barbara E Shykoff

Department of Medicine, State University of New York at Buffalo, Buffalo, NY, USA

Joseph L Izzo, Jr

Department of Medicine, State University of New York at Buffalo, Buffalo, NY, USA

Reversal by heparin of norepinephrine-induced constriction of normal hand veins was studied. Venous size was measured using a linear variable differential transformer (LVDT) during infusions of saline, norepinephrine, insulin and norepinephrine, and graded doses of heparin with norepinephrine. Heparin reduced the venoconstrictive effects of norepinephrine (p, 0.01), with the effects beginning at 18.5 nmol/min (0.05 U/min) and reaching a maximum between 185 nmol/min and 1.85 mmol/min (0.5 and 5 U/min). Maximal heparin-induced venorelaxation correlated with the maximal insulin effect within individuals (r = 0.8, p, 0.01) and was unchanged by the addition of insulin. Methylene blue, a non-specific inhibitor of the nitric oxide cGMP cascade, reduced heparin-induced venorelaxation. In conclusion, heparin in either physiologic or pharmacologic concentrations attenuated norepinephrine-induced venoconstriction. A common mechanism of venorelaxation by heparin and insulin is not excluded given the correlation and lack of additivity of maximum effects and their inhibition by methylene blue.

Key Words: endothelium • hand veins • LVDT • vascular reactivity • vasodilation

Vascular Medicine, Vol. 3, No. 2, 95-100 (1998)
DOI: 10.1177/1358836X9800300202


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. Margetts HEPARIN AND THE PERITONEAL MEMBRANE Perit. Dial. Int., January 1, 2009; 29(1): 16 - 19. [Full Text] [PDF]

				B. E Shykoff, F. I Hawari, and J. L Izzo Jr Diameter, pressure and compliance relationships in dorsal hand veins Vascular Medicine, May 1, 2001; 6(2): 97 - 102. [Abstract] [PDF]

				D. J. Horstman, L. G. Fischer, P. C. Kouretas, R. L. Hannan, and G. F. Rich Role of nitric oxide in heparin-induced attenuation of hypoxic pulmonary vascular remodeling J Appl Physiol, May 1, 2002; 92(5): 2012 - 2018. [Abstract] [Full Text] [PDF]